GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

envometinib   Click here for help

GtoPdb Ligand ID: 14073

Synonyms: example 274 [WO2023133472] | IMM-6-415
Compound class: Synthetic organic
Comment: Envometinib is the INN for a MEK inhibitor. It was included in WHO INN proposed list 133 (10th July 2025). Chemical structure match in patent WO2023133472 [1] suggests that this might be Immuneering Corporation's MEK clinical lead IMM-6-415.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 10
Hydrogen bond donors 2
Rotatable bonds 10
Topological polar surface area 125.66
Molecular weight 523
XLogP 0.34
No. Lipinski's rules broken 1

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CNS(=O)(=O)NC1=C(C(=CC=C1)CC2=C(CN(C)C)C3=C(C=C(C=C3)OC(=O)N(C)C)OC2=O)Cl
Isomeric SMILES CNS(=O)(=O)NC1=CC=CC(=C1Cl)CC2=C(C3=C(C=C(C=C3)OC(=O)N(C)C)OC2=O)CN(C)C
InChI InChI=1S/C23H27ClN4O6S/c1-25-35(31,32)26-19-8-6-7-14(21(19)24)11-17-18(13-27(2)3)16-10-9-15(33-23(30)28(4)5)12-20(16)34-22(17)29/h6-10,12,25-26H,11,13H2,1-5H3
InChI Key UNBQMQJVNBHLAP-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

References
1. Hall BM, Decorte BL, King PJ, Leenders R, Wegert A, Fowler K, Kolitz S, Doodeman R, Poelakker J, Folmer RHA. (2023)
Mek immune oncology inhibitors and therapeutic uses thereof.
Patent number: WO2023133472A1. Assignee: Immuneering Corporation. Priority date: 05/01/2023. Publication date: 13/07/2022.